Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avalo Therapeutics Inc
(NQ:
AVTX
)
9.540
-0.590 (-5.82%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,721
Open
10.12
Bid (Size)
9.010 (1)
Ask (Size)
10.50 (1)
Prev. Close
10.13
Today's Range
9.210 - 10.12
52wk Range
3.950 - 42.34
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 08, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Announces Participation in September Investor Conferences
September 04, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Performance
YTD
+9.53%
+9.53%
1 Month
+6.12%
+6.12%
3 Month
-24.58%
-24.58%
6 Month
-37.40%
-37.40%
1 Year
-73.30%
-73.30%
More News
Read More
AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024
August 12, 2024
Via
InvestorPlace
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 12, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
July 16, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
July 09, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
June 24, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
June 17, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023
May 24, 2024
Via
InvestorPlace
AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 02, 2024
Via
Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
April 02, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 02, 2024
Via
InvestorPlace
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
April 02, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
April 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 01, 2024
Via
InvestorPlace
Avalo Reports 2023 Financial Results and Provides Business Updates
March 29, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.